Found 11 matching trials
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
PHASE1This is a phase Ib/II Study of Leronlimab (PRO 140) combined with Carboplat...
Location
Quest Clinical Research
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation
PHASE2This is a Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Cen...
Location
University of Miami Sylvester Comprehensive Cancer Center
PRO 140 for Human Immunodeficiency Virus Infection
PHASE2PRO 140 2103 is a multicenter, randomized parallel group study, conducted i...
Location
Stanford University (Stanford AIDS Clinical Trials Unit)
An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study
PHASE2PRO 140\_CD02 Extension study seeks to evaluate the long-term efficacy, saf...
Location
Multiple Locations
The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)
PHASE2This is an open label, randomized, two arm, multi-center study to explore t...
Status
Active Not Recruiting
Location
City of Hope Orange County Lennar Foundation Cancer Center
PRO 140 in Treatment-Experienced HIV-1 Subjects
PHASE2The primary objectives of the trial are to assess the efficacy, clinical sa...
Location
CD02_OpenLabel Investigational Site
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
PHASE2This study is a Phase 2b/3, multi-center study designed to evaluate the eff...
Location
CD03 Investigational site
Oxidative Stress In Semen And Male Infertility
PHASE4The proposed research aims to study the effects of antioxidant therapy, com...
Location
Hamad Medical Corporation
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study
PHASE2This study is a Phase 2b/3 multi-center extension study designed to evaluat...
Location
Quest Clinical Research
PRO 140 for Human Immunodeficiency Virus
PHASE2PRO 140 2102 is a multicenter, randomized, double-blind, placebo-controlled...
Location
Drexel University